CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The GRASP project investigates the potential of a gonadotropin-releasing hormone antagonist to treat polycystic ovary syndrome (PCOS). It aims to assess its effects on hormonal dynamics and reproductive health in both animal models and women with PCOS.
PCOS is the most common endocrine disorder affecting up to 18% of women worldwide.
The syndrome imposes a heavy health burden, covering infertility, obesity, type 2 diabetes and metabolic syndrome.
The development of treatment options is an urgent need since there is currently neither a cure nor mechanism-based treatments, leaving patient management suboptimal and focused solely on symptomatic treatment.
One key neuroendocrine aberration in most women with PCOS is increased luteinizing hormone (…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Lille
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
